Form 4 for OCUL OCULAR THERAPEUTIX, INC

Accepted 2026-01-06 00:00:00 ET · period of report 2026-01-02 · accession 0001104659-26-001284 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2026-01-06	2026-01-02	OCUL	Heier Jeffrey S.	CSO	A - Grant	$0.00	+79.1K	326.4K	+32%	$0
D	2026-01-06	2026-01-02	OCUL	Heier Jeffrey S.	CSO	A - Grant	$0.00	+240.9K	240.9K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-01-02	A	A	79,112	$0.00	326,425	D	—	—	(F1) On January 2, 2026, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Corporation"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter. (F2) Includes 1,373 shares of common stock acquired under the Corporation's Amended and Restated 2014 Employee Stock Purchase Plan on December 31, 2025.
2	Derivative	Stock Option (Right to Buy)	2026-01-02	A	A	240,932	$0.00	240,932	D	$11.82 · — to 2036-01-01	240,932 Common Stock	(F3) Subject to the reporting person's continued service to the Corporation, the shares underlying this option vest over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.